Entering the Indian Pharmaceutical Market: A Practical Guide for European Pharma Companies India’s pharmaceutical market is massive, but it’s not an easy place for foreign…
Meat, poultry and seafood businesses face tighter FSSAI scrutiny in 2026 — new turnover thresholds, a sausage-standard deadline, and zero relaxation on hygiene audits.
CPCB just made life easier for anyone managing EPR accounts with their new “Lost Credentials” feature. If you’re stuck because your registered email or mobile
CDSCO Issues Guidance for Importing and Marketing Globally Unapproved New Drugs After Phase III Trials On August 10, 2026, the Central Drugs Standard Control Organisation
Why Your BIS Certification Application Gets Rejected—and What You Can Do About It Getting BIS Certification isn’t just another box to tick if you want
CDSCO has floated a tender to build a next-gen Digital Drugs Regulatory System while SUGAM adds new modules. Here’s what regulatory teams must track now.
India’s Central Drugs Standard Control Organization (CDSCO) just rolled out a new Guidance Document for importing and registering drugs—both bulk and finished formulations, as of
Biological Products Licenses and Approvals in India: Your Guide to the CDSCO Process by ACPL Group India – Regulatory Affairs Experts India has really carved
FSSAI has scrapped mandatory BIS certification for packaged drinking water and replaced it with a strict new testing regime from January 2026. Here’s what water bottlers must do now.
Importing medical devices into India isn’t simple—it’s tightly regulated by the Central Drugs Standard Control Organization, or CDSCO. The Central Licensing Authority (CLA), which is
